Insider filing · KYMR
Bruce N. Jacobs
Chief Financial Officer
profile →
Kymera Therapeutics, Inc.
KYMR · Healthcare · 59 filings in 24 months
ticker →
Bruce N. Jacobs sold $4.0M of Kymera Therapeutics (KYMR)
Executed Sep 17 2025, disclosed Sep 17 2025, the same day.
Value, as filed
$4.0M
79,220 sh × $50.00
Executed
Sep 17 2025
the trade date, as filed
Disclosed
Sep 17 2025
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
BJBruce N. Jacobs (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $8.9M of KYMR (77,109 sh across 8 lots, as filed), executed Jun 30.
The name
KYMRHealthcare · Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Bruce N. Jacobs in KYMR
KYMRSALE
Kymera Therapeutics, Inc.
$8.9M77,109 sh across 8 lots
Exec Jun 30
Filed Jul 2 · 6:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $1.0M
11,532 sh across 5 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $175K
5,754 sh × $30.33
Exec Mar 3 2025
Filed Mar 3 2025 · 5:30 PM ET